Skip to content
Global Access Atlas

Evidence & policy library

Every pathway is linked to the organizations responsible for the decision.

11 source records

Methodology

Pathway information draws on official regulator, HTA and payer materials. Consult the cited policy for its conditions and effective date, and see Content & use for guidance on applying Atlas to your research.

Content & use

Matching documents: 13

Market / scopeOfficial evidence recordTypePolicy / reference dateLast checked
Europe
🇦🇹 AustriaAT-S01 · BASG · Marketing authorisation & life-cycleOfficialAustrian authorisation and lifecyclecurrent procedureLatest observed: current 2026🇦🇹 AustriaAT-S02 · Dachverband der Sozialversicherungsträger · Pharmaceutical Evaluation Board (HEK)OfficialHEK advisory role and compositioncurrent mandateLatest observed: updated 2026🇦🇹 AustriaAT-S03 · RIS · ASVG §351cOfficialEKO application, boxes, clocks and EU priceeffective 2025-12-30Latest observed: current at check🇦🇹 AustriaAT-S04 · Dachverband · Erstattungskodex 2026OfficialEKO purpose, evaluation and HEK/Dachverband rolesEKO 1/2026Latest observed: published 2026🇦🇹 AustriaAT-S05 · Federal Ministry / GÖG · Price Commission method for EU averageOfficialEU average calculationmethod effective 2018-11-01Latest observed: file current at check🇦🇹 AustriaAT-S06 · RIS · KAKuG §19a Hospital medicines committeeOfficialhospital list, procurement guidance and board useeffective 2024-01-01Latest observed: current 2026🇦🇹 AustriaAT-S07 · Gesundheit Österreich GmbH · Introduction and operation of the BewertungsboardOfficialboard purpose and operationregular operation since 2024-09Latest observed: current at check🇦🇹 AustriaAT-S08 · Federal Ministry · FAQ BewertungsboardOfficialselective products and assessment scope2024 reformLatest observed: file current at check🇦🇹 AustriaAT-S09 · Austrian Health Portal · Financing the public health systemOfficialLänder funds and LKFcurrent frameworkLatest observed: current at check🇦🇹 AustriaAT-S10 · Austrian Health Portal · Health-insurance benefitsOfficialindividual approval for costly medicinescurrent public guidanceLatest observed: current at check🇦🇹 AustriaAT-S11 · European Commission / EMA · EU JCA early-information guidance and EMA IRIS coordinationOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02🇦🇹 AustriaAT-S11 · European Commission / EMA · EU JCA early-information guidance and EMA IRIS coordinationOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02🇦🇹 AustriaAT-S11 · European Commission / EMA · EU JCA early-information guidance and EMA IRIS coordinationOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02

For education only — not regulatory, pricing or legal advice.